Case study: Novel development in immune therapy against influenza A groups 1 and 2

The goal of all vaccine production, influenza vaccines included, is improved vaccines for all by increasing the breath of protection for longer lasting immunity. One such possible method to achieve this is the use of mAb (Monoclonal Antibodies) in vaccine production. Why not download this case study to discover more about this use of mAbs in the production of an …